Seneca Biopharma merges with Leading BioSciences, becoming Palisade Bio

Seneca Biopharma merges with Leading BioSciences, becoming Palisade Bio

Source: 
Fierce Biotech
snippet: 

Penny stock biotech Seneca Biopharma has found a lifeline in privately owned Leading BioSciences as it merges with the biotech.

Under the terms of the deal, the two companies will become known as Palisade Bio and trade on the Nasdaq under the ticker "PALI."